Oriens' Two-Part Financing Strategy Implemented: Non-Toxic Capital Drawdowns Begin

About this update from Regenerative Medical Technology Group Inc.

[{"type":"text","content":"\n \n \n Oriens' Two-Part Financing Strategy Implemented: Non-Toxic Capital Drawdowns Begin\n \n \nOriens' Two-Part Financing Strategy Implemented: Non-Toxic Capital Drawdowns Begin\n \n LAS VEGAS, NV--(Marketwired - Aug 4, 2014) - Oriens Travel & Hotel Management Corp. (OTC Pink: OTHM) (PINKSHEETS: OTHM), the Next Generation International Hotel Brand Operator, operating its Hotel PURE brand, announced today, that Oriens has officially commenced the process of financing the Jaco Beach acquisition/operations through a two-part strategy, as its Costa Rican allied partners have begun drawing down capital from traditional, non-toxic, asset based capital resources. \n In a previous announcement, management indicated it would look to deploy a two-part finance strategy. The first part being to seek traditional asset back financings to act as bridge capital; the second, to secure larger long-term equity based financing. \n \"Acquiring properties comes with a number of expenses; costs we have diligently looked to cover with the least amount of impact on the market,\" stated Ken Chua, President of Oriens Travel & Hotel Management. \"While we understand the second phase of our multi-million dollar raise will eventually incorporate long-term equity financing, current expenses are just below half a million dollars. We find it very important to responsibly facilitate this smaller size funding, though a financing vehicle offering the greatest benefit to our market and stakeholders. Through our allied partners in Costa Rica, along with friendly investors in the States, we have seemingly been fortunate enough -- so far, to access capital without registering or selling any corporate stock.\"\n Interestingly enough, because the acquisition process was partly delayed due to the excitement of Costa Rica's World Cup success, the estimated time of closing had been pushed back by roughly three weeks. Nonetheless, due to the strength of Oriens' key alliances, additional latitude was granted. This gave Oriens the ability to satisfy those obligations inherent to its various deal structures.\n Mr. Chua concluded, \"This process has certainly been challenging. What keeps us focused however, is the sheer value and confidence we expect will ultimately be delivered to our shareholders. When Oriens completes these acquisitions, re-launches our FROL, and...

More updates from Regenerative Medical Technology Group Inc.